Objective This systematic study aimed to assess and compare the comprehensive evidence
regarding the impact of neoadjuvant hormone therapy (NHT) on surgical and oncological …

Objective Docetaxel has been shown to be an effective chemotherapy agent when
combined with androgen deprivation therapy for hormone sensitive metastatic prostate …

Purpose We determine whether the nadir prostate-specific antigen level (PSA nadir) and
time to nadir (TTN) during initial androgen deprivation therapy (ADT) are prognostic factors …

Objectives To determine how frailty and comorbidities affect surgical contraindication in
patients with localized prostate cancer (CaP). Materials and methods We evaluated the …

Introduction We aimed to evaluate the treatment sequence for patients with metastatic
castration-resistant prostate cancer (mCRPC) in real-world practice and compare overall …

Objective To investigate the association of pain with frailty in patients with localized prostate
cancer (PC) who underwent robot‐assisted laparoscopic radical prostatectomy (RARP) …

Objective The present study aimed to evaluate oncologic outcomes, patient-reported
outcomes (PROs), and frailty in older adult patients aged≥ 75 years who underwent robot …

Objectives We aimed to evaluate the effect of frailty on health-related quality-of-life (HRQOL)
and lower urinary symptoms (LUTS) following robot-assisted radical prostatectomy (RARP) …

Background: Radical prostatectomy (RP) is the standard treatment in patients with high-risk
prostate cancer (PCa). However, there is a high rate of recurrence, and new approaches are …

Prostate cancer (PC) is the second most common cancer in men worldwide. The application
of the prostate-specific antigen (PSA) test has improved the diagnosis and treatment of PC …